Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00745407

Enrollment

Unknown

Registered

2008-09-03

Start date

2005-01-31

Completion date

2008-08-31

Last updated

2008-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemia

Keywords

adipocytokines, insulin sensitivity, hypertriglyceridemic patients

Brief summary

Fenofibrate increases adiponectin levels, but reduces leptin levels

Interventions

DRUGfenofibrate

Study design

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

25 Years to 80 Years

Healthy volunteers

Inclusion criteria

* hypertriglyceridemia

Exclusion criteria

* chronic liver disease

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026